OakChart

Scilex Holding Company

SCLXHealthcare·Drug Manufacturers - General·USA·Nano·NASD·Nov 11 • 3:59 PM ET

1.62+0.01 (0.62%)
2026-11-11 23:32 CET
Market cap
11.33 USD m
Revenue, TTM
31.61 USD m
Net income, TTM
-448.35 USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-49.80
P/E
-
Compare

Price

SCLX against its 20, 50 and 200-day averages
2050200
2.004.006.008.0010.001.2M2.3MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SCLXclose 1.6220-day 2.1250-day 3.55200-day 5.111.62

90.4% under the 52-week high of 16.81 on 21 Nov 2025. 52-week low 1.61 on 5 Nov 2026. Last 15 sessions, 61.5% high to low

Volume 0.29× normal · the line is the 50-bar volume average

Profile

SCLX
52-week range, 0% of the way up
1.6116.81

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Employees34
IPOMar 05, 2021
Beta1.85
ATR, 14d0.21
Rel volume0.29
Short float2.13%
Insider own11.67%
Inst own10.11%

Snapshot

6 groups

Valuation

Index-
Market Cap11.40M
Enterprise Value114.63M
Income-448.35M
Sales31.61M
Book/sh-43.83
Cash/sh0.08
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees34
IPOMar 05, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S0.36
P/B-
P/C19.66
P/FCF3.07
EV/EBITDA-
EV/Sales3.63
Quick Ratio0.06
Current Ratio0.07
Debt/Eq-
LT Debt/Eq-
Option/ShortNo / Yes

Earnings

EPS (ttm)-49.80
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y-81.59% -392.41%
Sales past 3/5Y-7.35% -
EPS Y/Y TTM-310.88%
Sales Y/Y TTM-28.55%
EPS Q/Q-124.28%
Sales Q/Q-22.78%
Earnings-
EPS/Sales Surpr.0.00% 0.00%

Ownership

Insider Own11.67%
Insider Trans0.00%
Inst Own10.11%
Inst Trans-2.86%
ROA-265.83%
ROE-
ROIC-
Gross Margin29.18%
Oper. Margin-903.52%
Profit Margin-1418.45%
SMA20-23.64%
SMA50-54.41%
SMA200-68.31%
Trades-

Technical

Shs Outstand7.03M
Shs Float6.21M
Short Float2.13%
Short Ratio3.23
Short Interest0.13M
52W High16.81 -90.36%
52W Low1.61 0.62%
Volatility9.74% 8.58%
ATR (14)0.21
RSI (14)15.12
Beta1.85
Rel Volume0.29
Avg Volume40.95K
Volume11,803

Performance

Perf Week-11.48%
Perf Month-43.75%
Perf Quarter-75.96%
Perf Half Y-60.46%
Perf YTD-78.67%
Perf Year-86.20%
Perf 3Y-94.24%
Perf 5Y-99.26%
Perf 10Y-
Recom3.00
Target Price392.26
Prev Close1.61
Price1.62
Change %0.62%

Analyst ratings

latest 6 of 6
DateActionAnalystRating changeTargetImplied
Jan 27, 2025InitiatedDD. Boral CapitalBuy$22+1,258.0%
Oct 16, 2024InitiatedAAlliance Global PartnersBuy$14+764.2%
Jun 13, 2024InitiatedRRodman & RenshawBuy$13+702.5%
Oct 16, 2023InitiatedRB. Riley SecuritiesBuy$4+146.9%
Oct 13, 2023InitiatedRB. Riley SecuritiesBuy$4+146.9%
Oct 09, 2023InitiatedHH.C. WainwrightBuy$12+640.7%

Peers

Mkt cap
TickerCompanyMkt cap
HRTXHeron Therapeutics Inc68.36M
PCRXPacira BioSciences Inc1.46B
TNXPTonix Pharmaceuticals Holding Corp75.20M
COLLCollegium Pharmaceutical Inc770.99M
AXSMAxsome Therapeutics Inc7.85B
TLPHTalphera Inc54.50M
AYTUAytu BioPharma Inc19.67M
DERMJourney Medical Corp125.31M
ANIKAnika Therapeutics Inc186.86M
VRTXVertex Pharmaceuticals Inc138.69B

Insider trading

3 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Scilex Holding Co10% OwnerDec 30 '25Sale0.549,657,3005,209,148244,445,260Dec 30 08:24 PM
Scilex Holding Co10% OwnerDec 29 '25Sale0.667,310,9844,792,350254,102,560Dec 30 08:24 PM
Scilex Holding Co10% OwnerDec 26 '25Sale0.753,689,0162,770,082261,413,544Dec 30 08:24 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B
AVTMAvantis Total Equity Markets ETFAUM: 758.92M

News

latest 14 of 174

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2025Q42026-02-25-0.470-0.470-4.70812.1012.101
2025Q32025-12-03-13.804-13.804-22.16810.5610.561
2025Q22025-09-03-7.420-0.910-7.4229.9026.251
2025Q12025-05-28-2.260-2.255-2.2555.005.001
2024Q42025-02-26-0.036-5.338-1.23414.9017.794
2024Q32024-11-27-4.025-3.150-1.21017.2917.873
2024Q22024-08-28-8.400-5.863-10.94417.3816.174
2024Q12024-05-29-7.438-8.400-8.33111.4210.882
2023Q42024-02-28-8.750-7.935-7.48913.4811.433
2023Q32023-11-29-16.916-11.435-8.89510.1111.373
2026Q1---0.337-6.279-15.001
2026Q2---0.291-16.647-16.001
2026Q3---0.121--17.001
2026Q4---0.144--18.001
2027Q1--0.181--45.351
2027Q2--0.234--47.241

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2023FY-40.135-35.000-44.85246.7344.72
2024FY-0.387-14.470-0.38756.5962.93
2025FY-32.320-32.320-36.47737.5637.56
2026FY--0.890--66.00
2027FY-0.730--188.97
2028FY-6.780--608.48
2029FY-10.900--944.18
2030FY-12.580--1,091

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q1S2026-03-1210115.0015.0015.00
2026Q1S2026-02-2510076.6076.6076.60
2026Q1S2025-12-0310076.6076.6076.60
2026Q1S2025-09-0310076.6076.6076.60
2026Q1S2025-05-2810076.6076.6076.60
2026Q1S2025-05-0110076.6076.6076.60
2026Q1R2026-03-12101-0.34-0.34-0.34
2026Q1R2026-02-251001.091.091.09
2026Q1R2025-12-031001.091.091.09
2026Q1R2025-09-031001.091.091.09
2026Q1R2025-05-281001.091.091.09
2026Q1R2025-05-011001.091.091.09
2026Q1E2026-04-15100-0.34-0.34-0.34
2026Q1E2026-03-12101-0.34-0.34-0.34

Estimate history

EPS, annual-0.013-23.294-6.092-44.852-19.432-36.477-49.8017
Period202020212022202320242025TTM
EPS, quarterly-10.944-1.21-1.234-2.255-7.422-22.168-4.708-6.279-16.647
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual031.31738.03446.74356.5930.25331.61
Period202020212022202320242025TTM
Sales, quarterly16.3714.43614.95.0049.89610.564.7938.6137.642
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.4933.7964.0392.8585.2367.0337.035
Period202020212022202320242025MRQ
Shares, quarterly3.4693.7635.2365.4935.4975.9487.0337.0337.035
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Total Revenue31.6130.2556.5946.7438.0331.320.00
Cost of Goods Sold Incl. D&A22.3915.2220.7419.8314.767.410.00
Gross Profit9.2215.0335.8526.9223.2823.900.00
Selling, General and Administrative Excl. Other294.81287.34128.64132.3573.9159.740.01
Research and Development18.6120.719.6412.759.059.20-
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-285.59-272.30-92.79-105.43-50.63-35.84-0.01
Interest Expense16.1811.461.961.079.6011.76-
Unusual Expense189.4883.83-21.997.70-36.9412.760.00
Net Income Before Taxes-464.55-374.03-72.81-114.32-23.36-88.42-0.01
Income Taxes0.010.03-0.000.010.000.010.00
Consolidated Net Income-465.79-417.81-72.81-114.33-23.36-88.42-0.01
Net Income From Continuing Operations-448.35-402.49-72.81-114.33-23.36-88.42-0.01
Net Income-448.35-402.49-72.81-166.98-23.36-88.42-0.01
EPS (Recurring)-45.81-31.16-23.54-43.40-12.84-20.94-0.01
EPS (Basic, Before Extraordinaries)-49.80-36.48-19.43-44.85-6.09-23.29-0.01
EPS (Diluted)-49.80-36.48-19.43-44.85-6.09-23.29-0.01
EBITDA-277.27-267.68-88.74-101.28-46.18-31.69-0.01
Non-Operating Income (Expense)26.69-6.44-0.04-0.12-0.07-28.050.00
Other After Tax Adjustments-1.23-43.750.000.000.000.000.00
Stock Option Compensation Expense12.4812.2512.3911.534.264.25-
Price To Earnings Ratio----24.92137.67-
Price To Sales Ratio1.704.450.995.6914.0842.59-
Gross Margin29.1849.6863.3657.5861.2076.33-
Operating Margin-903.52-900.09-163.96-225.55-133.13-114.44-
Net Margin-1,418.45-1,330.40-128.66-357.22-61.43-282.35-
Shares Outstanding7.037.035.242.864.043.800.49
Market Capitalization11.3311.3348.65119.5532.73107.84107.84

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue7.648.614.7910.569.905.0014.9014.44
Cost of Goods Sold Incl. D&A6.527.324.204.354.282.395.704.77
Gross Profit1.131.300.596.215.612.629.219.66
Selling, General and Administrative Excl. Other30.5533.4738.07192.7226.0330.5237.5832.08
Research and Development3.343.218.173.906.192.462.182.35
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-29.42-32.17-37.48-186.51-20.41-27.90-28.38-22.42
Interest Expense6.103.783.502.802.682.480.290.58
Unusual Expense73.5048.69-1.2268.5120.84-4.30-22.19-18.65
Net Income Before Taxes-114.98-45.65-46.10-257.82-44.03-26.08-6.46-4.39
Income Taxes0.010.000.010.000.020.00-0.000.00
Consolidated Net Income-116.22-45.65-46.11-257.82-87.80-26.08-6.46-4.39
Net Income From Continuing Operations-114.73-43.27-33.11-257.23-86.06-26.08-6.46-4.39
Net Income-114.73-43.27-33.11-257.23-86.06-26.08-6.46-4.39
EPS (Recurring)-9.18-1.33-4.83-18.04-6.16-2.52-4.20-4.81
EPS (Basic, Before Extraordinaries)-16.65-6.28-4.71-22.17-7.42-2.25-1.23-1.21
EPS (Diluted)-16.65-6.28-4.71-22.17-7.42-2.25-1.23-1.21
EBITDA-26.58-29.30-35.89-185.49-19.40-26.89-27.37-21.41
Non-Operating Income (Expense)-5.9538.99-6.34-0.00-0.100.000.01-0.05
Other After Tax Adjustments-1.230.000.000.00-43.750.000.000.00
Stock Option Compensation Expense2.842.874.072.702.593.311.513.71
Price To Sales Ratio1.701.362.845.661.541.981.382.13
Gross Margin14.7315.0612.3358.8056.7352.3061.7866.93
Operating Margin-385.02-373.49-782.02-1,766.21-206.27-557.51-190.46-155.29
Net Margin-1,501.30-502.38-690.84-2,435.93-869.65-521.18-43.36-30.40
Shares Outstanding7.037.037.035.955.505.495.243.76
Market Capitalization11.3335.2164.5085.2325.4929.7548.6575.83

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY
Cash & Short Term Investments10.983.273.922.184.340.03
Short Term Receivables15.2426.4434.6021.2414.270.00
Inventories4.792.444.211.382.560.00
Other Current Assets7.343.404.054.811.830.00
Total Current Assets38.3635.5546.7829.6123.000.03
Net Property, Plant & Equipment28.422.933.671.902.110.00
Total Investments and Advances160.402.420.810.000.000.00
Intangible Assets137.2845.9349.9754.0752.280.00
Other Assets0.526.120.090.940.540.17
Total Assets364.9892.95101.3186.5377.930.20
Short Term Debt Incl. Current Port. of LT Debt92.2839.70109.190.7458.060.12
Accounts Payable86.2752.6240.958.454.280.00
Income Tax Payable0.050.881.45---
Other Current Liabilities305.06166.4398.7935.65107.080.06
Total Current Liabilities483.65259.63250.3844.84169.420.18
Long Term Debt40.275.0519.270.6796.690.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities52.8120.914.594.7835.700.00
Total Liabilities576.73285.59274.2550.29301.810.18
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-207.78-192.64-172.9436.24-223.880.02
Total Shareholders Equity-207.78-192.64-172.9436.24-223.880.02
Accumulated Minority Interest-3.970.000.000.000.000.00
Total Equity-211.75-192.64-172.9436.24-223.880.02
Total Liabilities & Stockholders Equity364.9892.95101.3186.5377.930.20
Book Value Per Share-29.54-36.79-60.528.97-58.980.04
Tangible Book Value Per Share-49.06-45.57-78.00-4.42-72.750.04
Full-Time Employees341151059076-
Price to Book Ratio-0.04-0.25-0.730.37-12.40-10.97
Return on Assets-175.78-74.96-121.73-20.64-226.35-
Return on Equity----27.991.20-
Return on Invested Capital----63.31--33.52
Quick Ratio0.070.130.170.630.120.17
Current Ratio0.080.140.190.660.140.17

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Net Income-466.06-374.05-72.81-114.33-23.36-88.42-0.01
Depreciation8.314.624.054.154.454.15-
Other Funds (Non Cash)330.48259.2823.2723.68-48.0242.010.01
Funds from Operations-127.27-110.15-45.49-86.51-66.93-42.27-0.00
Extraordinary Item0.000.000.000.000.000.000.00
Changes in Working Capital110.00113.9764.8465.8045.6713.60-
Cash from Operating Activities-17.273.8219.35-20.71-21.26-28.66-0.00
Capital Expenditures-44.41-16.57-0.60-0.33-2.070.000.00
Net Assets From Acquisitions-9.07-9.000.000.000.000.000.00
Sale of Fixed Assets and Businesses1.541.520.000.000.000.000.00
Purchase or Sale of Investments78.5428.36-2.080.000.000.000.00
Purchase of Investments-11.58-11.24-2.080.000.000.000.00
Sale Or Maturity of Investments90.1239.610.000.000.000.000.00
Other Uses-21.90-0.230.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.00
Cash from Investing Activities3.974.08-2.68-0.33-2.070.000.00
Cash Dividends Paid0.000.000.000.000.000.000.00
Change in Capital Stock25.7327.8842.3834.610.100.00-0.09
Repurchase of Common Pref Stock-2.370.000.000.000.000.000.00
Sale of Common Pref Stock28.1127.8842.3834.610.100.00-0.09
Proceedsfrom Stock Options-2.76-2.7440.2733.470.100.00-0.09
Issuance or Reduction of Debt, Net0.00-2.81-58.3820.3553.5613.700.12
Change in Long Term Debt0.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-27.58-30.53-2.13-31.37-32.4814.460.00
Other Financing Activities Uses-29.11-30.56-2.13-31.37-87.76-33.390.00
Cash from Financing Activities11.04-5.46-18.1323.5821.1728.160.03
Exchange Rate Effect--0.76-----
Net Change in Cash-3.531.68-1.462.55-2.15-0.500.03
Free Cash Flow-3.6819.35-20.74-21.27-28.66-0.00
Preferred Dividends (Cash Flow)-----0.000.00
Price to Free Cash Flow-36.552.89----
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments0.583.3610.980.884.105.80
Short Term Receivables25.6429.8515.2411.9416.7710.62
Inventories4.174.534.791.082.523.02
Other Current Assets5.844.237.342.591.992.47
Total Current Assets36.2341.9738.3616.4925.3721.90
Net Property, Plant & Equipment26.8127.5528.422.392.572.76
Total Investments and Advances61.7783.93160.40212.982.472.46
Intangible Assets127.23138.63137.2843.9044.9244.93
Other Assets1.521.550.520.128.426.92
Total Assets253.56293.63364.98275.8883.7578.98
Short Term Debt Incl. Current Port. of LT Debt88.3988.0792.2855.3145.2344.48
Accounts Payable121.05101.5886.2767.3659.1657.26
Income Tax Payable0.070.140.050.020.180.66
Other Current Liabilities302.73311.96305.06236.26201.37173.34
Total Current Liabilities512.24501.75483.65358.95305.93275.74
Long Term Debt17.5918.2940.2712.364.144.32
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities34.2227.6652.8184.2922.6710.39
Total Liabilities564.05547.71576.73455.60332.74290.46
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-308.32-249.22-207.78-176.94-248.99-211.49
Total Shareholders Equity-308.32-249.22-207.78-176.94-248.99-211.48
Accumulated Minority Interest-2.17-4.85-3.97-2.780.000.00
Total Equity-310.49-254.07-211.75-179.72-248.99-211.48
Total Liabilities & Stockholders Equity253.56293.63364.98275.8883.7578.98
Book Value Per Share-43.83-35.44-29.54-29.75-45.29-38.50
Tangible Book Value Per Share-61.91-55.15-49.06-37.13-53.46-46.68
Full-Time Employees--34---
Price to Book Ratio-0.04-0.14-0.26-0.27-0.10-0.14
Return on Assets-265.83-225.26-175.78-199.75-130.63-87.55
Quick Ratio0.060.070.070.040.070.07
Current Ratio0.070.080.080.050.080.08

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-114.71-45.65-42.37-263.33-45.29-26.08
Depreciation2.832.871.561.051.051.00
Other Funds (Non Cash)86.3215.818.17220.1829.163.86
Funds from Operations-25.56-26.98-32.64-42.10-15.08-21.22
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital18.8325.8714.7650.5422.3627.23
Cash from Operating Activities-6.72-1.11-17.888.447.286.01
Capital Expenditures-5.90-22.25-16.24-0.15-0.16-0.15
Net Assets From Acquisitions0.000.00-9.070.000.000.00
Sale of Fixed Assets and Businesses0.010.001.530.000.000.00
Purchase or Sale of Investments16.3033.3928.640.20-0.01-0.25
Purchase of Investments0.45-0.95-11.280.20-0.01-0.25
Sale Or Maturity of Investments15.8534.3439.930.000.000.00
Other Uses-1.37-20.30-0.02-0.200.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities8.45-9.164.83-0.16-0.16-0.40
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.00-0.00--
Change in Capital Stock-2.350.0018.659.430.020.00
Repurchase of Common Pref Stock-2.370.000.000.000.000.00
Sale of Common Pref Stock0.020.0018.659.430.020.00
Proceedsfrom Stock Options0.000.00-1.75-1.020.000.00
Issuance or Reduction of Debt, Net-2.147.6415.96-8.58-7.81-2.39
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.001.50-16.66-12.41-1.01-0.69
Other Financing Activities Uses0.000.00-16.66-12.45-1.01-0.69
Cash from Financing Activities-4.499.1417.95-11.57-8.80-3.08
Exchange Rate Effect-0.02-0.48----
Net Change in Cash-2.78-1.604.14-3.28-1.692.53
Free Cash Flow---18.018.447.286.01
Price to Free Cash Flow--23.119.483.246.28

Revenue breakdown

Biological Products, (No Diagnostic Substances)2024: 56.59M 2025: 30.25M
United States2024: 56.59M 2025: 30.25M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.13%0.1M6.2M42.20K
2026-10-152.39%0.1M6.2M52.07K
2026-09-302.76%0.2M6.2M94.73K
2026-09-152.85%0.2M6.2M105.74K
2026-08-312.56%0.2M6.2M120.13K
2026-08-142.03%0.2M7.5M144.85K
2026-07-312.34%0.2M7.5M170.46K
2026-07-152.79%0.2M7.5M175.78K
2026-06-302.34%0.2M7.0M132.98K
2026-06-152.90%0.2M7.0M124.90K
2026-05-293.27%0.2M7.0M71.69K
2026-05-152.26%0.2M7.0M57.09K
2026-04-302.41%0.2M7.0M46.73K
2026-04-152.27%0.2M7.0M46.52K
2026-03-312.68%0.2M7.0M52.90K
2026-03-132.72%0.2M7.0M61.53K
2026-02-273.13%0.2M7.0M67.88K
2026-02-133.32%0.2M7.0M90.70K
2026-01-302.64%0.2M7.0M101.87K
2026-01-152.44%0.2M7.0M115.60K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-09-298-KCurrent report2026-09-25SEC
2026-08-24SCHEDULE 13D/ASEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-128-KCurrent report2026-08-08SEC
2026-07-228-KCurrent report2026-07-18SEC
2026-07-07SCHEDULE 13D/ASEC
2026-07-074Statement of changes in beneficial ownership of securities2026-07-03SEC
2026-07-068-KCurrent report2026-07-03SEC
2026-06-30S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-298-KCurrent report2026-06-24SEC
2026-06-26SCHEDULE 13D/ASEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-248-KCurrent report2026-06-24SEC
2026-06-11EFFECTEffectiveness filing by commission orderSEC
2026-06-09CORRESPSEC
2026-06-09UPLOADUpload SubmissionSEC
2026-06-02S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-05-22EFFECTEffectiveness filing by commission orderSEC
2026-05-20CORRESPSEC
2026-05-2010-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-15NT 10-Q2026-03-31SEC
2026-05-118-KCurrent report2026-05-11SEC
2026-05-05DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-05-058-KCurrent report2026-05-04SEC
2026-04-30ARSAnnual report to security holders. 2025-12-31SEC
2026-04-30DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-24SEC
2026-04-30CORRESPSEC
2026-04-288-KCurrent report2026-04-26SEC
2026-04-24UPLOADUpload SubmissionSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120012.77M3
2025-110000

Institutional holders

Manager% owned
VANGUARD CAPITAL MANAGEMENT LLC3.55%
BlackRock, Inc.1.29%
VANGUARD FIDUCIARY TRUST CO0.54%
JACOBS LEVY EQUITY MANAGEMENT, INC0.48%
UBS Group AG0.45%
STATE STREET CORP0.42%
RENAISSANCE TECHNOLOGIES LLC0.39%
Ashton Thomas Private Wealth, LLC0.34%
CITADEL ADVISORS LLC0.32%
PRICE T ROWE ASSOCIATES INC /MD/0.25%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.56%
VANGUARD EXTENDED MARKET INDEX FUND0.90%
iShares Micro-Cap ETF0.28%
iShares Core S&P Total U.S. Stock Market ETF0.17%
T. Rowe Price Extended Equity Market Index Fund0.08%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND0.04%
VANGUARD BALANCED INDEX FUND0.04%
1290 VT Micro Cap Portfolio0.02%
MetLife Russell 2000 Index Portfolio0.01%
SIIT EXTENDED MARKET INDEX FUND0.00%

OakChart. SCLX. Cached 15 minutes.